                         SEQUENCE LISTING

<110>  Beijing Xuanyi PharmaSciences Co., Ltd.
       Song, Yuntao
 
<120>  THERAPEUTIC AGENTS AND CONJUGATES THEREOF

<130>  CSPL-011/02WO 332638-2070

<150>  US 63/062,503
<151>  2020-08-07

<150>  US 62/986,223
<151>  2020-03-06

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR9 agonist


<220>
<221>  misc_feature
<222>  (1)..(30)
<223>  joined by phosphorothioate bonds

<400>  1
tcgaacgttc gaacgttcga acgttcgaat                                        30


<210>  2
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR9 agonist


<220>
<221>  misc_feature
<222>  (1)..(22)
<223>  joined by phosphorothioate bonds

<220>
<221>  modified_base
<222>  (3)..(3)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  modified_base
<222>  (7)..(7)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  modified_base
<222>  (11)..(11)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  misc_feature
<222>  (11)..(12)
<223>  glycerol linker

<220>
<221>  modified_base
<222>  (12)..(12)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  modified_base
<222>  (16)..(16)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  modified_base
<222>  (20)..(20)
<223>  2'-deoxy-7-deazaguanosine

<400>  2
tcnaacnttc nncttncaan ct                                                22


<210>  3
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR9 agonist

<400>  3
gggggggggg gacgatcgtc gggggggggg                                        30


<210>  4
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TLR9 agonist


<220>
<221>  misc_feature
<222>  (1)..(24)
<223>  joined by phosphorothioate bonds

<400>  4
tcgtcgtttt gtcgttttgt cgtt                                              24


